Literature DB >> 24939623

Predictors of hemodynamic instability during surgery for pheochromocytoma.

Colleen M Kiernan1, Liping Du, Xi Chen, James T Broome, Chanjuan Shi, Mary F Peters, Carmen C Solorzano.   

Abstract

BACKGROUND: Resection of pheochromocytoma is often associated with hemodynamic instability (HDI). We examined patient and tumor factors that may influence HDI. The effect of pretreatment with nonselective α blockade phenoxybenzamine (PXB) versus selective α blockade on HDI and outcomes was also evaluated.
METHODS: The records of 91 patients who underwent adrenalectomy between 2002 and 2013 were retrospectively reviewed. HDI was determined by number of intraoperative episodes of systolic blood pressure (SBP) > 200 mmHg, those greater than or less than 30 % of baseline, heart rate > 110 bpm, and the need for postoperative vasopressors. Fishers exact, t test and regressions were performed.
RESULTS: Among 91 patients, 78 % received PXB, 18 % selective α blockade and 4 % no adrenergic blockade. Patient demographics, tumor factors and surgical approach were similar among the blockade groups. On multivariate analysis, increasing tumor size was associated with a significant rise in the number of episodes of SBP > 30 % [rate ratio (RR) 1.40] and an increased postoperative vasopressor requirement [odds ratio (OR) 1.23]. Open adrenalectomy and use of selective blockade were associated with an increased number of episodes of SBP > 200 mmHg (RR 27.8 and RR 20.9, respectively). Open adrenalectomy was also associated with increased readmissions (OR 12.3), complications (OR 5.6), use of postoperative vasopressors (OR 4.4) and hospital stay (4.6 days longer). There were no differences in other HDI measurements or postoperative outcomes among the blockade groups.
CONCLUSIONS: Tumor size, open adrenalectomy, and type of α blockade were associated with intraoperative HDI during pheochromocytoma resection. Selective blockade was associated with significantly more episodes of intraoperative hypertension but no perioperative adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939623      PMCID: PMC4192065          DOI: 10.1245/s10434-014-3847-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

1.  Clinical experience over 48 years with pheochromocytoma.

Authors:  R E Goldstein; J A O'Neill; G W Holcomb; W M Morgan; W W Neblett; J A Oates; N Brown; J Nadeau; B Smith; D L Page; N N Abumrad; H W Scott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

2.  Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.

Authors:  Anouk Scholten; Menno R Vriens; Geert Jan E Cromheecke; Inne H M Borel Rinkes; Gerlof D Valk
Journal:  Eur J Endocrinol       Date:  2011-04-15       Impact factor: 6.664

3.  Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.

Authors:  Yu Zhu; Hong-chao He; Ting-wei Su; Yu-xuan Wu; Wei-qing Wang; Ju-ping Zhao; Zhoujun Shen; Chong-yu Zhang; Wen-bin Rui; Wen-long Zhou; Fu-kang Sun; Guang Ning
Journal:  Endocrine       Date:  2010-07-18       Impact factor: 3.633

4.  Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma.

Authors:  Toby N Weingarten; Juan P Cata; Jerome F O'Hara; David J Prybilla; Tasha L Pike; Geoffrey B Thompson; Clive S Grant; David O Warner; Emmanuel Bravo; Juraj Sprung
Journal:  Urology       Date:  2010-05-23       Impact factor: 2.649

5.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

6.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

7.  Clinical spectrum of pheochromocytoma.

Authors:  Marlon A Guerrero; Jennifer M J Schreinemakers; Menno R Vriens; Insoo Suh; Jimmy Hwang; Wen T Shen; Jessica Gosnell; Orlo H Clark; Quan-Yang Duh
Journal:  J Am Coll Surg       Date:  2009-12       Impact factor: 6.113

8.  Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.

Authors:  H Bruynzeel; R A Feelders; T H N Groenland; A H van den Meiracker; C H J van Eijck; J F Lange; W W de Herder; G Kazemier
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

9.  Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program.

Authors:  James Lee; Mahmoud El-Tamer; Tracy Schifftner; Florence E Turrentine; William G Henderson; Shukri Khuri; John B Hanks; William B Inabnet
Journal:  J Am Coll Surg       Date:  2008-03-24       Impact factor: 6.113

10.  Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases.

Authors:  Giovanni Conzo; Mario Musella; Francesco Corcione; Maurizio Depalma; Francesco Stanzione; Cristina Della-Pietra; Antonietta Palazzo; Salvatore Napolitano; Daniela Pasquali; Marco Milone; Antonio Agostino-Sinisi; Fausto Ferraro; Luigi Santini
Journal:  Am Surg       Date:  2013-11       Impact factor: 0.688

View more
  32 in total

Review 1.  [Anesthetic management during pheochromocytoma surgery : Current strategies].

Authors:  B J Nottebaum; H Groeben
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

2.  Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience.

Authors:  Cyrille Buisset; Carole Guerin; Pierre-Julien Cungi; Mickael Gardette; Nunzia-Cinzia Paladino; David Taïeb; Thomas Cuny; Frederic Castinetti; Frederic Sebag
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

Review 3.  Is there any role for minimally invasive surgery in NET?

Authors:  M Thomaschewski; H Neeff; T Keck; H P H Neumann; T Strate; E von Dobschuetz
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 4.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

Review 5.  Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Magdalena Pisarska; Michał Pędziwiatr; Andrzej Budzyński
Journal:  Gland Surg       Date:  2016-10

Review 6.  Surgical treatment of adrenal tumors during pregnancy.

Authors:  Marisa A Bartz-Kurycki; Sophie Dream; Tracy S Wang
Journal:  Rev Endocr Metab Disord       Date:  2022-07-01       Impact factor: 9.306

7.  Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.

Authors:  Reese W Randle; Courtney J Balentine; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2016-08-25       Impact factor: 5.344

Review 8.  Surgical approach to patients with pheochromocytoma.

Authors:  Dhaval Patel
Journal:  Gland Surg       Date:  2020-02

9.  Risk factors for hemodynamic instability during laparoscopic pheochromocytoma resection: a retrospective cohort study.

Authors:  Magdalena Pisarska-Adamczyk; Karolina Zawadzka; Krzysztof Więckowski; Krzysztof Przęczek; Piotr Major; Michał Wysocki; Piotr Małczak; Michał Pędziwiatr
Journal:  Gland Surg       Date:  2021-03

10.  Incidence, risk factors and clinical significance of postoperative haemodynamic instability after adrenalectomy for phaeochromocytoma.

Authors:  Joseph P Thompson; Davinia Bennett; James Hodson; Miriam Asia; John Ayuk; Michael W O'Reilly; Niki Karavitaki; Wiebke Arlt; Robert P Sutcliffe
Journal:  Gland Surg       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.